Endocrine Society takes strong stance against custom-compounded bioidentical hormone productsNo rationale for routine prescribing of these unregulated, untested, potentially harmful products. Pharmacy innovation: two steps forward, one step backSpeakers shared ground-breaking research and cautionary advice in equal measure at the Canadian Foundation for Pharmacy’s Innovation Gala dinner in Toronto last week N.S. health minister calls for review of prescription drug monitoring program Call follows charges against doctor who allegedly sold more than 50,000 Oxycodone and other prescription narcotics. Largest study of its kind shows benefits of Medtronic insulin pumps for people with type 2 diabetes UK pharmacy chain accused of abusing med review program Media reports allege Boots uses quotas to pressure pharmacists into conducting unneeded medication reviews. B.C. declares public health crisis over rise in opioid-related overdoses Hundreds of pharmacists participate in naloxone training sessions as college fast-tracks drug’s conversion to non-prescription status in response to emergency. ASA use for the primary prevention of cardiovascular disease and colorectal cancer US task force issues updated recommendations that balance benefits and harms. Ontario pharmacists’ expanded scope of practice Details start emerging about timelines for new practice activities. Device a solution to drug shortages? MIT develops portable drug factory that can be used to produce medications on demand. Empowering pharmacists to make interventions lowers patients' cardiac risk: study Findings from RxEACH, a University of Alberta research project, were presented at a U.S. cardiology conference. First Previous 664 665 666 667 668 Next Last
